ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GILD announcements Gilead Sciences, Inc. announcements and dividends declared NASDAQ

Gilead Sciences, Inc. Complete list of announcements declared & dividend announcements by Gilead Sciences, Inc. GILD

Gilead Sciences, Inc. GILD listed on NASDAQ and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Gilead Sciences, Inc. GILD

Gilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why
Gilead Sciences (GILD) closed at .78 in the latest trading session, marking a -1.58% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.27% for the day. Elsewhere, the Dow gained 0.43
Announcement as on 14 December 2023

Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Gilead Sciences (GILD) closed the latest trading day at .02, indicating a +1.24% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily gain of 0.41%. Meanwhile, the Dow gained
Announcement as on 08 December 2023

Gilead Sciences Presents Three-year Outcomes From BICSTaR Study With Biktarvy
(RTTNews) - Gilead Sciences, Inc. (GILD) reported new long-term real-world data from the BICSTaR study highlighting the safety and efficacy profile of Biktarvy as a treatment regimen for a broad range of people with HIV, including those with a prior treat
Announcement as on 19 October 2023

5 Reasons Gilead Sciences is a Better Buy Than You Think
Shares of Gilead Sciences (NASDAQ: GILD) are down roughly 20% from their highs in 2023 and, like other stocks in correction this year, are showing signs of a bottom. The price pressure in 2023 is due primarily to the COVID-19 cliff; Gilead’s business
Announcement as on 10 October 2023

: Gilead Sciences says FDA has approved Veklury in COVID patients with severe kidney disease
Gilead Sciences Inc. GILD said Friday the U.S. Food and Drug Administration has approved the use of its Veklury, or remdesivir, for patients with severe renal impairment, including those on dialysis. Veklury is now the only approved COVID antiviral for peo
Announcement as on 14 July 2023

Announcements by Gilead Sciences, Inc. first page | Next page | Prev page |

GILD Gilead Sciences, Inc. current price & indicator signals

Moving Averages for Gilead Sciences, Inc.

  • 5Day Average: 138
  • 12Day Average: 138.61
  • 20Day Average: 141.45
  • 50Day Average: 144.81
  • 100Day Average: 134.05
  • 150Day Average: 128.14
  • 200Day Average: 124.29

GILD Indicators & signals

Indicator MACD (12,26,9)

139.54, 141.44, -1.7
Indicator MACD is in negative zone

Indicator ADX (14)

5.59, 20.32, 22.73
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GILD Gilead Sciences, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Apr 2026 139.71 138.00 to 141.34 -0.42% 0.36 times
01 Wed Apr 2026 140.30 138.82 to 141.49 0.67% 1.04 times
31 Tue Mar 2026 139.37 137.17 to 140.35 2.2% 1.54 times
30 Mon Mar 2026 136.37 133.89 to 141.70 1.58% 0.51 times
27 Fri Mar 2026 134.25 134.10 to 137.47 -1.92% 1.11 times
26 Thu Mar 2026 136.88 136.66 to 138.94 -1% 0.84 times
25 Wed Mar 2026 138.26 137.92 to 140.42 0.11% 0.99 times
24 Tue Mar 2026 138.11 136.47 to 138.37 0.56% 1.32 times
23 Mon Mar 2026 137.34 136.44 to 139.80 0.07% 1.44 times
20 Fri Mar 2026 137.25 136.49 to 142.47 -2.73% 0.83 times
19 Thu Mar 2026 141.10 140.12 to 142.28 -2.29% 0.39 times
17 Tue Mar 2026 144.40 143.27 to 146.71 -0.56% 0.76 times

Videos related to: GILD announcements Gilead Sciences, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

GILD announcements Gilead Sciences, Inc. announcements and dividends declared NASDAQ

 

Back to top